Skip to main content
Category

Media Placements

FDA Grants Orphan Drug Designations to VBI, Hepion Cancer Drugs [BioSpace]

https://www.biospace.com/article/fda-approves-orphan-drug-designations-for-vbi-hepion-cancer-drugs/

Tackling Liver Disease with a Multimodal Cyclophilin Inhibitor [Pharma’s Almanac]

https://www.pharmasalmanac.com/articles/tackling-liver-disease-with-a-multimodal-cyclophilin-inhibitor?hs_preview=FMelfVXS-74910818711
Media Placements

Can Hepion Pharmaceuticals Develop the First Treatment Approved For NASH? With Robert Foster, Pharm D, PhD [Biotech IQ]

JTNDYSUyMGhyZWYlM0QlMjJodHRwcyUzQSUyRiUyRnRoZWJpb3RlY2hpcXBvZGNhc3QuY29tJTJGY2FuLWhlcGlvbi1waGFybWFjZXV0aWNhbHMtZGV2ZWxvcC10aGUtZmlyc3QtdHJlYXRtZW50LWFwcHJvdmVkLWZvci1uYXNoLXdpdGgtcm9iZXJ0LWZvc3Rlci1waGFybS1kLXBoZCUyMiUyMHRhcmdldCUzRCUyMl9ibGFuayUyMiUyMHJlbCUzRCUyMm5vb3BlbmVyJTIyJTNFJTNDaW1nJTIwc3JjJTNEJTIyaHR0cHMlM0ElMkYlMkZ0aGViaW90ZWNoaXFwb2RjYXN0LmNvbSUyRndwLWNvbnRlbnQlMkZ1cGxvYWRzJTJGMjAyMiUyRjA0JTJGR3JhcGhpY3MtRWdvQmFpdC1CVEktNDctUm9iZXJ0LUZvc3Rlci5wbmclMjIlMjAlMkYlM0UlM0MlMkZhJTNF
Hepion
May 4, 2022

Q&A With Robert Foster, CEO of Hepion Pharmaceuticals [Pharm Exec]

https://www.pharmexec.com/view/q-a-with-robert-foster-ceo-of-hepion-pharmaceuticals

Hepion Striving to Repeat History by Developing its Second FDA-Approved Drug [via Benzinga]

https://www.benzinga.com/general/biotech/21/03/20282078/hepion-striving-to-repeat-history-by-developing-its-second-fda-approved-drug

Hepion Pharmaceuticals employing artificial intelligence to tackle NASH [BioTuesdays]

https://hepionpharma.com/wp-content/uploads/2020/11/BioTuesdays-November-2020.pdf